BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38590378)

  • 21. Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis.
    Zhang X; Sun Y; Zhang Y; Chen F; Zhang S; He H; Song S; Tse G; Liu Y
    Front Cardiovasc Med; 2021; 8():697221. PubMed ID: 34409076
    [No Abstract]   [Full Text] [Related]  

  • 22. Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction.
    Wohlfahrt P; Nativi-Nicolau J; Zhang M; Selzman CH; Greene T; Conte J; Biber JE; Hess R; Mondesir FL; Wever-Pinzon O; Drakos SG; Gilbert EM; Kemeyou L; LaSalle B; Steinberg BA; Shah RU; Fang JC; Spertus JA; Stehlik J
    JAMA Cardiol; 2021 Aug; 6(8):957-962. PubMed ID: 33950162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
    Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin Resistance Is Associated With Heart Failure With Recovered Ejection Fraction in Patients Without Diabetes.
    Yang CD; Pan WQ; Feng S; Quan JW; Chen JW; Shu XY; Aihemaiti M; Ding FH; Shen WF; Lu L; Zhang RY; Wang XQ
    J Am Heart Assoc; 2022 Oct; 11(19):e026184. PubMed ID: 36129062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and predictors of heart failure with improved ejection fraction category in a HFrEF patient population.
    Solymossi B; Muk B; Sepp R; Habon T; Borbély A; Heltai K; Majoros Z; Járai Z; Vágány D; Szatmári Á; Sziliczei E; Bánfi-Bacsárdi F; Nyolczas N
    ESC Heart Fail; 2024 Apr; 11(2):783-794. PubMed ID: 38124459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes.
    Park JJ; Mebazaa A; Hwang IC; Park JB; Park JH; Cho GY
    J Am Heart Assoc; 2020 Jun; 9(12):e015009. PubMed ID: 32519555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of improvement of left ventricular systolic function after catheter ablation of persistent atrial fibrillation in patients with heart failure with reduced ejection fraction.
    Ukita K; Egami Y; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Tanaka A; Matsunaga-Lee Y; Yano M; Shutta R; Sakata Y; Nishino M; Tanouchi J
    Heart Vessels; 2021 Aug; 36(8):1212-1218. PubMed ID: 33744995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure.
    Dong M; Wang L; Tse G; Dai T; Wang L; Xiao Z; Liu T; Ren F
    BMC Cardiovasc Disord; 2023 Jan; 23(1):34. PubMed ID: 36653770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The E/e' ratio on echocardiography as an independent predictor of the improvement of left ventricular contraction in patients with heart failure with reduced ejection fraction.
    Yoshimura R; Hayashi O; Horio T; Fujiwara R; Matsuoka Y; Yokouchi G; Sakamoto Y; Matsumoto N; Fukuda K; Shimizu M; Izumiya Y; Yoshiyama M; Fukuda D; Fujimoto K; Kasayuki N
    J Clin Ultrasound; 2023 Sep; 51(7):1131-1138. PubMed ID: 37363957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of left ventricular ejection fraction in patients with heart failure with reduced ejection fraction: Predictors and clinical impact.
    Perea-Armijo J; López-Aguilera J; Sánchez-Prats R; Castillo-Domínguez JC; González-Manzanares R; Ruiz-Ortiz M; Mesa-Rubio D; Anguita-Sánchez M;
    Med Clin (Barc); 2023 Jul; 161(1):1-10. PubMed ID: 37019757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients.
    Oh JH; Lee JM; Lee HJ; Hwang J; Lee CH; Cho YK; Park HS; Yoon HJ; Chung JW; Kim H; Nam CW; Han S; Hur SH; Youn JC; Kim IC
    ESC Heart Fail; 2022 Aug; 9(4):2435-2444. PubMed ID: 35484930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trajectory change of left ventricular ejection fraction after rhythm control for atrial fibrillation in heart failure.
    Si J; Sun Y; Bai L; Tse G; Ding Z; Zhang X; Zhang Y; Chen X; Xia Y; Liu Y
    ESC Heart Fail; 2024 Apr; 11(2):681-691. PubMed ID: 38097279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses.
    Wang X; Fan X; Wu Q; Liu J; Wei L; Yang D; Bu X; Liu X; Ma A; Hayashi T; Guan G; Xiang Y; Shi S; Wang J; Fang J
    Front Cardiovasc Med; 2022; 9():853870. PubMed ID: 35911515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and prognosis of heart failure with normal left ventricular ejection fraction in elderly patients.
    Liu DP; Wang F; Zeng XZ; Zhang XC
    Chin Med J (Engl); 2012 Aug; 125(16):2853-7. PubMed ID: 22932079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Kitai T; Miyakoshi C; Morimoto T; Yaku H; Murai R; Kaji S; Furukawa Y; Inuzuka Y; Nagao K; Tamaki Y; Yamamoto E; Ozasa N; Tang WHW; Kato T; Kimura T
    JAMA Netw Open; 2020 May; 3(5):e204296. PubMed ID: 32379331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis and diastolic dysfunction predictors in patients with heart failure and recovered ejection fraction.
    Takada T; Matsuura K; Minami Y; Abe T; Yoshida A; Kishihara M; Watanabe S; Shirotani S; Jujo K; Hagiwara N
    Sci Rep; 2022 May; 12(1):8768. PubMed ID: 35610337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
    Naser N
    Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.